Home / Nieuws / ...
Verbetering opname kurkuma*
Uit verschillende studies blijkt dat een speciaal supplement bestaande uit een combinatie van kurkuma en soja-lecithine de opname van de bioactieve stoffen in kurkuma aanzienlijk doet verbeteren, tot wel bijna dertig keer. Verschillende leveranciers van kurkuma in capsules bevatten deze geregistreerde vorm, Meriva.
Absorption Of Curcuminoids Increased 29-Fold With Meriva(R)
In a new comparative absorption study published in the Journal of Natural Products MerivaŽ, an Indena proprietary formulation of curcumin with soy lecithin, has shown a marked increase of absorption in comparison to plain curcumin.
In this randomized, double-blind, crossover study, a collaboration between USANA and Indena scientists, the plasma concentration of the three curcuminoids present in commercial curcumin (curcumin, demethoxycurcumin and bisdemethoxycurcumin) was measured in nine volunteers after supplementation with two dosages of MerivaŽ and one dosage of a corresponding curcuminoid mixture. Subjects consumed five (low-dose) or nine (high-dose) capsules of MerivaŽ, corresponding to 209 and 376 mg total curcuminoids, or, alternatively, five capsules of the corresponding non-formulated curcuminoid mixture containing 1799 mg of total curcuminoids.
The results showed that the overall curcuminoid absorption was about 29-fold higher for MerivaŽ compared to the unformulated curcuminoid mixture, while a 50 to 60-fold higher absorption was observed for demethoxycurcumin and bisdemethoxycurcumin. The improved absorption, and possibly also a better plasma curcuminoid profile, might underlie the clinical efficacy of MerivaŽ at doses significantly lower than unformulated curcuminoid mixtures. [2-4]
Commenting on the results of the study Giovanni Appendino, Professor of Organic Chemistry at the University of Eastern Piedmont and Indena Scientific Advisor, said: "this MerivaŽ study represents one of the more significant advances in turmeric research. For the first time, a dramatic formulation-dependent increase in the bioavailability of curcuminoids in humans has been demonstrated, highlighting that curcuminoids have different absorption properties, and that the presence of lipids, as in MerivaŽ and in the traditional culinary use of turmeric, critically magnifies them. These results will open up new areas of clinical research on curcumin, rationalizing the clinical efficacy of MerivaŽat dosages much lower than those of curcumin, and successfully addressing the issue of megadoses that has plagued the clinical research on curcumin."
Curcumin is the yellow pigment of turmeric (Curcuma longa L.), the most important spice of the Indian cuisine, and a major ingredient of curry powders. In Asian Medicine, turmeric is used for the treatment of inflammation and joint pain. In Western countries, it is mainly employed as a food additive to color dairy products (cheese and yogurts), margarine and canned food. With over 100 molecular targets identified and almost 3,000 pre-clinical investigations, curcumin is one of the best investigated natural products of the whole biomedical literature; these studies have demonstrated its action as a master switch of inflammation. Nevertheless, just like most dietary phenolics, curcumin shows a very poor oral absorption. These problems have now been largely overcome by the patented formulation of curcumin with soy phospholipids that is capitalizing the basic tenets of the PhytosomeŽ strategy to improve the bioavailability by offering a higher stability and oral absorption in comparison with unformulated curcumin.
MerivaŽ is a patented formulation of curcumin, a dietary phenolic, with soy phospholipids. The two ingredients are combined in a 1:2 weight ratio, and two parts of microcrystalline cellulose are then added to improve the flowability, with an overall content of curcumin of 20%. MerivaŽ is already included as an ingredient in food supplements marketed in USA, Canada and EU.
MerivaŽ has been elected "Best New Product" of the year by the judging panel of the European Outsourcing Awards.
1. Cuomo, J., et al., Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation. J Nat Prod, 2011. Full study available here.
2. Belcaro, G., et al., Product-evaluation registry of Meriva(R), a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis. Panminerva Med, 2010. 52(2 Suppl 1): p. 55-62. Full study available here.
3. Belcaro, G., et al., Efficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev, 2010. 15(4): p. 337-44. Full study available here.
4. Allegri, P., A. Mastromarino, and P. Neri, Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol, 2010. 4: p. 1201-6. Full study available here.
USANA Health Sciences, Inc.
Indena (Augustus 2011)
Het mengen met zwarte peper zoals beschreven bij kurkuma zal volgens eerdere onderzoeken vergelijkbare resultaten geven, doch voor de eenvoud kunnen capsules wel eens handig zijn.